AgeX Therapeutics, Inc. (AGE)

Operating Income Growth

-21.90%

Quarterly · Period ending:

AGE logo

AGE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-21.90%
AGE Quarterly Operating Income YoY % (12.08% → -21.90%)
High-resolution chart · PNG

AGE operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Operating Income Growth — Quarterly
Period endingOperating Income Growth
-21.9048%
100%
-11.858%
-20.3313%
-43.9472%
-152.3912%
-55.8708%
-125.4669%
-104.9841%
-7.5533%
-99.7755%
-52%
-18.5418%
-5.1657%
4.5528%
7.4074%
27.8458%
10.5102%
23.7025%
30.3661%
16%
28.2316%
9.9043%
26.685%
23.7362%
-2.3382%
19.1185%
-48.9101%
-61.2933%
12.0811%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.